Lannett Company (LCI) announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution, 5 mg/5 mL, the therapeutic equivalent to the reference drug, Roxane Laboratories' Diazepam Oral Solution, 5 mg/5 mL. According to IMS, the U.S. wholesale market is ~$4M.